Agili-C
Country: Israel
Language: Hebrew
Source: Ministry of Health
Send request.
Available from:
Cartiheal (2009) Ltd.
Class:
בית חולים
Manufactured by:
Cartiheal (2009) Ltd.
Therapeutic group:
רופא
Therapeutic indications:
Agili-C implant is a bi-phasic, porous resorbable tissue regeneration scaffold for the treatment of focal articular cartilage and/or osteochondral defects. It is indicated for cartilage and/or bone repair. The implant serves as a scaffold for cellular and matrix ingrowth. The Agili-C implant is expected to biodegrade within 6 – 12 months.
Product summary:
Agili-C implant is a bi-phasic, porous resorbable tissue regeneration scaffold for the treatment of focal articular cartilage and/or osteochondral defects. It is indicated for cartilage and/or bone repair. The implant serves as a scaffold for cellular and matrix ingrowth. The Agili-C implant is expected to biodegrade within 6 – 12 months.
